EUVIMEDEUVIMED entdecken
Open Access

Quantitative Susceptibility Mapping and Iron Deposition in Autopsy‐Confirmed Progressive Supranuclear Palsy

Ryota Satoh iD, Hiroaki Sekiya iD, Farwa Ali, Dennis W Dickson, Jennifer L Whitwell iD, Keith A Josephs iD

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.70357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Ryota Satoh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Iron, Brain, Brain Mapping. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Quantitative susceptibility mapping ( QSM ) is a promising neuroimaging biomarker for detecting abnormal iron deposition in progressive supranuclear palsy ( PSP ); however, the QSM profile and its accuracy in autopsy‐confirmed PSP remain unexplored.

Objective

The aim of the study was to elucidate and validate the QSM profiles in autopsy‐confirmed PSP.

Methods

Eight patients with a clinically diagnosed PSP syndrome ( PSPS ) underwent antemortem 3 T magnetic resonance imaging ( MRI) scanning and subsequent pathological diagnosis, confirming 6 PSP pathology and 2 multiple system atrophy ( MSA ) pathology cases. QSM analysis and Prussian blue staining were performed across subcortical regions.

Results

PSP cases showed higher susceptibility than age‐matched controls in the pallidum, subthalamic nucleus, substantia nigra, and cerebellar dentate (false discovery rate [ FDR] ‐corrected P < 0.05). PSP had higher susceptibility in the subthalamic nucleus and lower susceptibility in the putamen than the clinically atypical MSA ( P = 0.08). Subcortical susceptibilities correlated with Prussian blue–stained areas ( r = 0.63, P < 0.001).

Conclusions

QSM could be a reliable measure to evaluate abnormal iron accumulation patterns in PSP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveIronBrainBrain MappingHumansMaleFemaleAgedMagnetic Resonance ImagingAutopsyMiddle AgedMultiple System AtrophyAged, 80 and over

Stichwörter der Autor:innen

PSPPrussian blueQSMironquantitative susceptibility mapping

Substanzen

Iron

Autor:innen und Institutionen

  • Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Ryota Satoh, Hiroaki Sekiya, Jennifer L Whitwell, Keith A Josephs

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Satoh, R., Sekiya, H., Ali, F., Dickson, D. W., Whitwell, J. L., & Josephs, K. A. (2025). Quantitative Susceptibility Mapping and Iron Deposition in Autopsy‐Confirmed Progressive Supranuclear Palsy. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70357

Vancouver

Satoh R, Sekiya H, Ali F, Dickson DW, Whitwell JL, Josephs KA. Quantitative Susceptibility Mapping and Iron Deposition in Autopsy‐Confirmed Progressive Supranuclear Palsy. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70357

BibTeX
@article{Satoh2025,
  author = {Satoh, Ryota and Sekiya, Hiroaki and Ali, Farwa and Dickson, Dennis W and Whitwell, Jennifer L and Josephs, Keith A},
  title = {Quantitative Susceptibility Mapping and Iron Deposition in Autopsy‐Confirmed Progressive Supranuclear Palsy},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.70357}
}
Kostenlos starten →